Anuh Pharma Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Anuh Pharma at Rs 80.13 is a pharma and healthcare company whose share price target of Rs 81.00 for 2027 represents approximately 1 percent upside from the current market price. The Anuh Pharma share price target rises to Rs 89.00 by 2028 and Rs 108 by 2030, implying a 4-year upside of approximately 35 percent from August 2026 levels. Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹4.1 and a fair multiple of approximately18x (moderating to approximately8% growth long-term), the stock's valuation trend point.

The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the Anuh Pharma share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.

Click Here – Get Free Investment Predictions

Anuh Pharma Company Overview

Metric	Details
NSE Ticker	ANUHPHR
Sector	Pharma and Healthcare
CMP (06 Aug 2026)	Rs 80.13
Market Cap	Rs 807 Cr
FY26 EPS	Rs 4.1 (8% annual growth)
Anuh Pharma Share Price Target 2027	Rs 81.00 (+1%)
Anuh Pharma Share Price Target 2028	Rs 89.00 (+11%)
Anuh Pharma Share Price Target 2030	Rs 108 (+35%)
Bull Case 2030	Rs 138
Bear Case 2030	Rs 81

What most investors miss: Part of the SK Group (approximatelyRs8.5bn group revenue) spanning formulations, trading, distribution and logistics

Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹4. 1 and a fair multiple of approximately18x (moderating to approximately8% growth long-term), the stock's valuation trend points to the figures above. The share price target of Rs 81.00 for 2027 and Rs 108 for 2030 reflect this earnings trajectory.

Why Is the Anuh Pharma Share Price Target Set at Rs 81.00 for 2027

Domestic Branded Formulations Revenue Growth

This is the primary driver of the Anuh Pharma share price target for 2027 and 2030. Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹4.1 and a fair multiple of approximately18x (moderating to approximately8% growth long-term), the stock's v. Investors tracking this metric quarterly will have the earliest signal of whether the Anuh Pharma share price target timeline is on track.

Export Markets and Regulatory Compliance Track Record

The Anuh Pharma share price target of Rs 81.00 for 2027, rising to Rs 108 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the Anuh Pharma share price target thesis.

Product Pipeline and New Launch Capability

This structural factor underpins the long-term Anuh Pharma share price target of Rs 108 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.

Manufacturing Scale and Cost Efficiency

For the Anuh Pharma share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 89.00 target in 2028 when earnings quality is most clearly visible.

India's Healthcare Spending Growth Is a Structural Tailwind

India's long-term economic growth trajectory creates a secular tailwind for Anuh Pharma's business that amplifies the company-specific earnings compounding embedded in the Anuh Pharma share price target 2030 of Rs 108 (+35% from CMP Rs 80.13).

Anuh Pharma Share Price Targets 2027, 2028 and 2030

Anuh Pharma Share Price Target 2027: Rs 81.00

The Anuh Pharma share price target 2027 is Rs 81.00, representing approximately 1 percent upside from CMP Rs 80.13. Assuming approximately10% annual earnings growth off a FY26 base EPS of ₹4.1 and a fair multiple of approximately18x (moderating to approximately8% growth long-term), the stock's valuation trend point. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the Anuh Pharma share price target.

Anuh Pharma Share Price Target 2028: Rs 89.00

The Anuh Pharma share price target 2028 is Rs 89.00, implying approximately 11 percent upside from CMP. By FY29, Anuh Pharma should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the Anuh Pharma share price target thesis typically triggers institutional re-rating toward the Rs 89.00 level.

Anuh Pharma Share Price Target 2030: Rs 108

The Anuh Pharma share price target 2030 is Rs 108, implying approximately 35 percent upside from CMP and a 4-year CAGR of approximately 8 percent. By FY31, Anuh Pharma should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.

Bull Case and Bear Case for Anuh Pharma Share Price Target 2030

Bull Case: Rs 138

The bull case Anuh Pharma share price target of Rs 138 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.

Bear Case: Rs 81

The bear case Anuh Pharma share price target of Rs 81 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.

Scenario	Target 2030	Return
Bull Case	Rs 138	+72%
Base Case	Rs 108	+35%
Bear Case	Rs 81	+1%

Key Risks to the Anuh Pharma Share Price Target

USFDA Compliance and Inspection Risk

Any regulatory action on Anuh Pharma's manufacturing facilities could delay product launches and reduce the Anuh Pharma share price target earnings.

Currency Risk on Export Revenue

INR appreciation against USD and EUR reduces the INR value of Anuh Pharma's international revenues and the Anuh Pharma share price target EPS.

Generic Pricing Pressure in Export Markets

Intensifying competition in US and European generic markets compresses pricing and the Anuh Pharma share price target margin assumptions.

Clinical and Approval Timeline Risk

Delays in pipeline product approvals would push revenue ramp-up beyond the Anuh Pharma share price target timeline.

How to Invest in Anuh Pharma

Use the Univest Screener to track Anuh Pharma's quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker ANUHPHR. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the Anuh Pharma share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.

Use the Univest Screener to Track This Stock Live

Conclusion

The Anuh Pharma share price target of Rs 81.00 for 2027, Rs 89.00 for 2028, and Rs 108 for 2030 reflects analyst consensus earnings compounding in the pharma and healthcare sector. The 4-year upside of approximately 35 percent from CMP Rs 80.13 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.

Download the Univest iOS App or Univest Android App to track Anuh Pharma share price live and get daily stock recommendations.

Frequently Asked Questions on Anuh Pharma Share Price Target 2027 2028 and 2030

What is the Anuh Pharma share price target for 2027?

Ans. The Anuh Pharma share price target for 2027 is Rs 81.00, representing approximately 1 percent upside from CMP Rs 80.13 as of August 2026. Please verify all data at NSE India before investing.

What is the Anuh Pharma share price target for 2030?

Ans. The Anuh Pharma share price target for 2030 is Rs 108, implying approximately 35 percent upside from CMP Rs 80.13. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.

What is the Anuh Pharma share price target for 2028?

Ans. The Anuh Pharma share price target for 2028 is Rs 89.00, implying approximately 11 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.

Is Anuh Pharma a good long-term investment?

Ans. Anuh Pharma has a defined analyst projection for earnings compounding through FY31 in the pharma and healthcare sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.

What are the key risks to the Anuh Pharma share price target?

Ans. Key risks include sector-specific headwinds such as usfda compliance and inspection risk, currency risk on export revenue, and broader macro slowdowns. Please review the full risks section in this article before investing.

What is the bull case for Anuh Pharma share price by 2030?

Ans. The bull case Anuh Pharma share price target for 2030 is Rs 138, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.

What is Anuh Pharma's current market cap?

Ans. Anuh Pharma has a market cap of approximately Rs 807 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.

How can I invest in Anuh Pharma?

Ans. You can buy Anuh Pharma shares through any SEBI-registered broker by searching for NSE ticker ANUHPHR. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.